GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NewAmsterdam Pharma Co NV (FRA:KH6) » Definitions » Total Stockholders Equity

NewAmsterdam Pharma Co NV (FRA:KH6) Total Stockholders Equity : €264.46 Mil (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is NewAmsterdam Pharma Co NV Total Stockholders Equity?

NewAmsterdam Pharma Co NV's Total Stockholders Equity for the quarter that ended in Dec. 2023 was €264.46 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. NewAmsterdam Pharma Co NV's Book Value per Share for the quarter that ended in Dec. 2023 was €3.21. The ratio of a company's debt over equity can be used to measure how leveraged this company is. NewAmsterdam Pharma Co NV's Debt-to-Equity for the quarter that ended in Dec. 2023 was 0.00.

NewAmsterdam Pharma Co NV Total Stockholders Equity Historical Data

The historical data trend for NewAmsterdam Pharma Co NV's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NewAmsterdam Pharma Co NV Total Stockholders Equity Chart

NewAmsterdam Pharma Co NV Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Total Stockholders Equity
-3.62 49.89 405.98 264.46

NewAmsterdam Pharma Co NV Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Total Stockholders Equity Get a 7-Day Free Trial 49.89 182.24 405.98 423.56 264.46

NewAmsterdam Pharma Co NV  (FRA:KH6) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

NewAmsterdam Pharma Co NV's Book Value per Share for the quarter that ended in Dec. 2023 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(264.456-0)/82.4698
=3.21

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

NewAmsterdam Pharma Co NV's Debt-to-Equity for the quarter that ended in Dec. 2023 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(0.055 + 0) / 264.456
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NewAmsterdam Pharma Co NV Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of NewAmsterdam Pharma Co NV's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

NewAmsterdam Pharma Co NV (FRA:KH6) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NewAmsterdam Pharma Co NV (FRA:KH6) » Definitions » Total Stockholders Equity
Comparable Companies
MDXG VERV AKRO ADMA ICPT SLNO INVA OLMA NVAX COGT OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
NAMS:USA KH6:Germany
Address
Gooimeer 2-35, Naarden, NH, NLD, 1411 DC
Website
https://www.newamsterdampharma.com
NewAmsterdam Pharma Co NV is a clinical-stage company focused on the research and development of transformative therapies for metabolic diseases and Alzheimer's disease.

NewAmsterdam Pharma Co NV (FRA:KH6) Headlines

No Headlines